PROTECT III Data

TCT 2019 Breakfast Symposium PROTECT III Presentation

PROTECT III Study

TCT 2019 Breakfast Symposium presented by Dr. Jeffrey J. Popma

New PROTECT III Data Demonstrates Impella®
Reduces MACCE at Primary Endpoint

Jeffrey J. Popma, MD, presents new data from ongoing FDA post-approval study for PROTECT II RCT

Subscribe here for exclusive updates from ProtectedPCI.com

Please complete all required* user information.

By completing this form, you are consenting to receiving emails regarding updates to the program, downloadable templates, case reviews, specialists opinions, and best practices.

Your personal information is important to us. Review our Privacy Policy and Terms of Use to learn how Abiomed protects your data.

TCT 2019 Breakfast Symposium PROTECT III Presentation

PROTECT III Study

New PROTECT III Data Demonstrates Impella® Reduces MACCE at Primary Endpoint

New PROTECT III Data Demonstrates Impella®
Reduces MACCE at Primary Endpoint